Home/Pipeline/Glatiramer Acetate (Generic Copaxone)

Glatiramer Acetate (Generic Copaxone)

Multiple Sclerosis

ApprovedCommercial

Key Facts

Indication
Multiple Sclerosis
Phase
Approved
Status
Commercial
Company

About Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is a vertically integrated pharmaceutical company with capabilities spanning drug discovery, development, manufacturing, and commercialization. The company has built a strong portfolio of generic drugs, particularly in the US market, while also investing in complex generics, biosimilars, and proprietary drug development. With manufacturing facilities across multiple countries and a global workforce, Dr. Reddy's continues to expand its market presence through strategic partnerships, acquisitions, and new product launches. The company is publicly traded on both Indian stock exchanges and NASDAQ, reflecting its status as a major player in the global pharmaceutical industry.

View full company profile

Other Multiple Sclerosis Drugs

DrugCompanyPhase
Zeposia (ozanimod)Bristol Myers SquibbCommercial
Copaxone (glatiramer acetate)Teva Pharmaceutical IndustriesCommercial
Multiple Sclerosis PortfolioBiogenCommercial
Kesimpta (ofatumumab)GenmabApproved
Glatiramer AcetateCiplaCommercial
Interferon β-1aBachemCommercial
KYV-101Kyverna TherapeuticsPhase 1/2
Azer-cel (PBCAR0191)Precision BioSciencesPhase 1/2
CYMS101FibroBiologicsPre-clinical / Limited Clinical